A phase 1b, open label, multicenter study evaluating the safety and efficacy of ipatasertib in combination with rucaparib in patients with advanced breast, ovarian or prostate cancer [BO40933].
- Pook, David (Primary Chief Investigator (PCI))
- Baker, Emma (Project Manager)
Project: Research